As stated in our extensive report, the Global Bone Graft Substitutes Market accounted forUSD 2.7 Billionin 2021.
Bone graft alternatives are used to repair broken bones or replace missing ones. They don't trigger an antigen-antibody reaction and are bioresorbable by nature. These qualities are frequently utilized in spinal, ankle,face, foot,and trauma procedures to heal fractures and bone injuries. Due to their osteogenic,osteoconductive,and osteoinductive qualities, bone grafts are implantable materials that support osseous repair, bone production, and healing of the bone. They are employed in spinal, plastic, facial, sports, and trauma surgery. They can also be used to fill in gaps where there are no bones or to help with structural stability. A surgeon can replace a missing or damaged bone using a substance (bone transplant) from the patient's body, a corpse, an animal, or another person. It has uses for difficult fracture treatment, wound healing, and other things.
Introducing new polymer and ceramic materials with physiologically superior properties is one of the major market trends currently being seen. The creation of free-form biomaterial scaffolds for tissue regeneration is aided by new manufacturing technologies like fast prototyping and 3D printing. Additionally, there is a growing demand for bone grafts and substitutes because of increased morbidity rates, an aging population, and an increase in osteoarthritis cases. Along with this, a shift toward minimally invasive procedures and patients' greater understanding of the advantages of bone regeneration using biologics are fueling the market's expansion.
The availability of advanced products in various sizes and forms, the rising incidence of orthopedic issues and periodontal illnesses, and the expanding number of studies looking into how to improve the bioactivity of Bone Graft Substitutes are a few more growth-inducing aspects. Lack of bone development or partial bone formation, unfavorable tissue reactions, and infections of the bone and soft tissue are a few of the substitutes' growing clinical problems. As a result, this factor will be anticipated to restrain market growth over the projection period. These restrictions and the rising risks associated with using these products have prompted the U.S. FDA and the manufacturers to recall the goods. It is anticipated that these recalls will discourage consumers from using alternatives, hurting the companies' ability to build their brands.
North Americaholds the largest market share of the Bone Graft Substitutes Market over the forecast period. The market expansion in North America is anticipated to be boosted by the increase in synthetic replacements introduced by market players due to their quick uptake in developed nations. Additionally, the presence of a sizable patient base suffering from bone injuries, combined with an increase in orthopedic procedures in the area, is anticipated to fuel market expansion. The demand for these alternatives is also anticipated to rise throughout the forecast period due to rising favorable health reimbursement for bone graft surgeries, significant Research and Development (R&D) expenditure, and growing market participants' focus on introducing new products in the area.
Some of the key and prominent players in the Global Bone Graft Substitutes Market include- Allo Source, Baxter, DePuy Synthes Inc., Medtronic, Nuvasive Inc., Orthofix Holdings Inc., Smith & Nephew Inc., Stryker Corporation, Wright Medical Group N.V., OST Development, Zimmer Biomet, Geistlich Pharma AG, TBF Tissue Engineering, Biobank, and others.